DOCN: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net income attributable to common stockholders	233,602	75,231	38,204	66,226
Depreciation and amortization	97,035	61,975	29,210	100,825
Stock-based compensation	60,313	40,513	19,432	67,659
Provision for expected credit losses	13,337	8,607	4,197	12,018
Gain on extinguishment of debt, net	48,104	-269	-	-
Deferred income taxes	72,522	-	-	0
Operating lease right-of-use assets and liabilities, net	7,746	13,816	7,192	-2,861
Non-cash interest expense	5,451	4,005	2,003	5,987
Net accretion of discounts and amortization of premiums on investments	0	0	0	-2,569
Release of vat reserve	-	-	-	0
Impairment of certain long-lived assets	0	0	-	356
Other	7,652	7,853	2,091	2,572
Accounts receivable	25,060	17,064	8,319	18,768
Prepaid expenses and other current assets	4,875	-1,201	1,255	13,594
Accounts payable and accrued expenses	18	-3,029	-11,492	1,136
Deferred revenue	3,190	5,867	245	235
Other assets and liabilities	-5,337	-631	-1,148	13,552
Net cash provided by operating activities	252,324	156,537	64,090	211,386
Capital expenditures - property and equipment	102,931	95,160	61,963	132,886
Capital expenditures - internal-use software development	6,541	3,412	2,029	6,492
Cash paid for acquisition of businesses, net of cash acquired	-	-	-	0
Cash paid for asset acquisitions	-	-	-	0
Acquisition of equipment under financing arrangement	27,622	-	-	-
Purchase of marketable securities	-	-	-	0
Purchase of intangible assets	1,835	1,835	983	-
Maturities of marketable securities	0	0	0	91,675
Purchased interest on marketable securities	-	-	-	0
Proceeds from interest on marketable securities	-	-	-	0
Proceeds from sale of equipment	157	-	-	42
Net cash used in investing activities	-138,772	-100,407	-64,975	-47,661
Payment of debt issuance costs	-	4,081	-	-
Proceeds related to issuance of common stock under equity incentive plan	3,628	2,771	1,941	11,890
Proceeds from issuance of common stock under employee stock purchase plan	2,660	2,660	-	2,231
Employee payroll taxes paid related to net settlement of equity awards	22,222	16,294	8,718	21,166
Proceeds from debt, net of issuance costs-Convertible Senior Notes Due2030	606,827	-	-	-
Purchases of capped calls related to 2030 convertible notes-Convertible Senior Notes Due2030	83,875	-	-	-
Proceeds from debt, net of issuance costs-A2025Credit Facility	375,919	-	-	-
Repayments of 2026 convertible notes including related costs-Convertible Senior Notes Due2026	1,131,458	-	-	-
Proceeds from financing arrangement	27,622	-	-	-
Principal repayments of finance leases	4,154	2,733	1,350	4,097
Repurchase and retirement of common stock including related costs	82,124	79,199	59,052	29,878
Net cash used in financing activities	-307,177	-96,876	-67,179	-41,020
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	-7	45	39	-69
(decrease) increase in cash, cash equivalents and restricted cash	-193,632	-40,701	-68,025	122,636
Cash and cash equivalents at beginning of period	430,193	430,193	430,193	318,983
Cash and cash equivalents at end of period	236,561	389,492	362,168	441,619

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

DOCN: the cashflow